Jotin Marango - Jan 18, 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTO)

Role
Senior VP, CFO, and CBO
Signature
/s/ Janet Clennett as attorney-in-fact for Jotin Marango
Stock symbol
APTO
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 04:17 PM
Previous filing
Aug 23, 2021
Next filing
Apr 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Employee Stock Option Award $0 +600K $0.00 600K Jan 18, 2022 Common Shares 600K $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent (50%) of the options vest on 1/18/2023; the remaining 50% vest as follows: 1/3 on 1/18/2024; 1/3 on 1/18/2025; and 1/3 on 1/18/2026.